About 18 million children under the age of 5 in the United States could soon be eligible to get a COVID-19 vaccine -- but first, the child-sized shot must go through a rigorous authorization process that's taking a different path than the COVID-19 vaccines that came before.
Local News 8's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
3 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Pfizer asks FDA for emergency approval of COVID-19 vaccine for kids under 5
Headline from Fox32 Chicago ·
Names this update
COVID-19 vaccine for younger children will face an 'odd' authorization process
Headline from Local News 8 ·
Newest
Adolescents aged 16 to 17 can now get their COVID boosters. Why not younger children?
Pfizer on Tuesday asked the U.S. to authorize extra-low doses of its COVID-19 vaccine for children under 5, potentially opening the way for the very youngest Americans to start receiving shots as early as March.
U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children six months to 5 years old while awaiting data on a three-dose course, aiming to clear the way for the shots as soon as late February, a person familiar with th…
U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children 6 months to 5 years old
Pfizer and BioNTech plan to submit a request for emergency use authorization for their COVID-19 vaccine in children six months to 5 years old as soon as Tuesday, which would set the vaccine up to be approved for young children in the coming weeks, the Washington Post reports.
Regulators urge drugmaker to apply for emergency authorization of 2-dose regimen of shot for kids aged 6 months to 5 years old while awaiting data on 3-dose course
Pfizer and BioNTech said Tuesday that the companies had asked the Food and Drug Administration (FDA) to authorize their COVID-19 vaccine for emergency use in children younger than 5 years old.
Pfizer asked the Food and Drug Administration Tuesday to authorize two low-dose shots for children between six months and 5 years old. Dr. Yvonne Maldonado, a professor of pediatric infectious disease at Stanford University who has helped conduct trials for the under-5 vaccine, joins Judy Woodruff t…
Children 6 months to 5 years old are one step closer to receiving the Pfizer COVID-19 vaccine after the company officially submitted the two-dose regimen to the FDA for emergency approval.
If approved by US regulators, children as young as 6-months-old will get two extra-low doses of the BioNTech-Pfizer COVID-19 vaccine. It is still unclear whether they will need two shots or three.
By Jacqueline Howard, CNN Children younger than 5 in the United States could begin receiving Covid-19 vaccinations this month or next if the US Food and Drug Administration moves quickly to authorize the shot for this age group.
The first big hurdle was crossed when Pfizer shared its clinical trial data with the FDA. Now there are five more steps get through before this vulnerable population can finally be vaccinated.
By Jacqueline Howard, CNN Children younger than 5 in the United States could begin receiving Covid-19 vaccinations this month or next if the US Food and
On Tuesday, Pfizer officially submitted its request to the FDA for emergency use authorization of its COVID-19 vaccine for children 6 months to 5 years old. Sources familiar with the discussions told the Associated Press on Monday that U.
